Inhalation device having an integrated electronic module - Patent application
The integration of an electronic module in inhalation devices addresses adherence and compliance issues by monitoring and enhancing patient interaction, ensuring effective drug delivery and treatment efficacy.
Patent Information
- Application Number
- JP2022103184
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2016-12-06
- Filing Date
- 2022-06-28
- Publication Date
- 2025-01-23
- Estimated Expiration
- 2037-12-05
AI Technical Summary
Existing inhalation devices face challenges in ensuring patient adherence and compliance due to physical limitations and the inability to detect proper drug delivery, particularly in patients with limited lung function or those using medications without odor or taste, leading to reduced therapeutic efficacy.
Incorporation of an electronic module in inhalation devices to sense, track, and process usage parameters, including inhalation metrics, and communicate with external devices to enhance adherence and compliance, featuring a controller, sensor system, power management, and communication circuitry to provide feedback and data analysis.
The electronic module improves patient adherence and compliance by providing real-time feedback and data analysis, ensuring proper drug delivery and monitoring inhalation quality, thereby enhancing the effectiveness of therapeutic treatments.
Smart Images

Figure 0007620595000004 
Figure 0007620595000005 
Figure 0007620595000006
Abstract
Description
[Technical Field]
[0001] [CROSS-REFERENCE TO RELATED APPLICATIONS] This application claims the benefit of U.S. Provisional Patent Application No. 62 / 430,576, filed December 6, 2016, the disclosure of which is incorporated herein by reference in its entirety. [Background technology]
[0002] Drug delivery devices facilitate the delivery of medications into a patient's body via various routes of administration. Typical routes of administration include oral, topical, sublingual inhalation, injection, etc. The devices can be used to deliver medications to treat various diseases, illnesses, and medical conditions. For example, inhalation devices can be used to treat asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis (CF). While drug delivery devices are designed to deliver an appropriate dose of medication to a patient as part of a therapeutic treatment, the effectiveness of a particular treatment can be affected by non-physiological factors such as patient adherence and compliance.
[0003] In drug therapy, adherence can refer to the degree to which a patient follows the prescribed medication regimen.For example, if a patient's prescription requires two doses every day, and the patient takes two doses per day, the patient can be considered to be 100% adherent.If the patient only takes one dose per day, the patient can be considered to be only 50% adherent.In the latter case, the patient may not receive the treatment prescribed by the patient's doctor, which may have a negative impact on the efficacy of the therapeutic treatment.
[0004] Compliance can refer to a patient's technique when using a particular drug delivery device. If a patient uses the device in the manner recommended by a physician or manufacturer, the device is likely to deliver the desired dose of medication, and the patient can be considered compliant. However, if the device is not used properly during medication administration, the device's ability to deliver the appropriate dose may be impaired. Therefore, the patient can be considered noncompliant. In the case of an inhalation device, for example, the patient may need to achieve a minimum inspiratory effort to ensure that the entire dose of medication is delivered from the device to the patient's lungs. For some patients, such as children and the elderly, physical limitations, such as limited lung function, may make it difficult to meet the requirements for complete compliance. Therefore, similar to adherence, failure to achieve complete compliance can reduce the effectiveness of the prescribed treatment.
[0005] A patient's ability to achieve full compliance can be further complicated by some physical characteristics of the medication. For example, some respiratory medications may consist of fine particles and / or lack any odor or taste. Thus, a patient using an inhalation device may not be able to immediately detect or sense that the medication is being inhaled and / or may not know whether the amount of medication inhaled is in accordance with the prescription, and therefore the patient may not be able to correct non-compliant use. DISCLOSURE OF THE INVENTION
[0006] [overview] A drug delivery device may be adapted to include an electronic module configured to sense, track, and / or process usage conditions and parameters associated with the device (e.g., to improve adherence and compliance). The electronic module may be further configured to communicate the conditions and parameters to an external device, such as a smartphone, for similar and / or further processing. The inclusion of an electronic module in a drug delivery device opens the door to a wealth of digital improvements and features, enhancing the use of the device. In this regard, the electronic module may create a platform for leveraging useful smartphone applications and powerful data analytics. However, the introduction of electronics into any drug delivery device may introduce certain technical challenges, such as durability, reliability, electro-mechanical integration, power management, and drug delivery performance. The present disclosure provides a solution for including some electrical components in a drug delivery device, such as an inhaler.
[0007] Examples of inhalation devices (e.g., breath-actuated inhalers) are provided herein. The inhalation device may include a body (e.g., a circular body) and electronics for an electronic module. The body may include a mouthpiece, one or more flexible strips of medicament (e.g., blister strips), a lever, and a mouthpiece cover rotatable about the body. Rotating the mouthpiece cover from a closed position to an open position may expose the mouthpiece and may further expose the lever for actuation by a user. Actuating the lever from the closed position to the open position may advance the flexible strip of medicament to prepare a dose of medicament for delivery to the user and / or expose a powder outlet such that a blister of medicament is in fluid communication with the mouthpiece (e.g., for delivery to the user). The electronic module may include a controller, communication circuitry, a sensor system, a switch, a power source, and memory. The lever may be configured to actuate (e.g., press) a switch when the lever moves from a first position (e.g., an open position) to a second position (e.g., a closed position) and / or to actuate (e.g., release) a switch when the lever moves from a second position (e.g., a closed position) to the first position (e.g., an open position). When actuated by the lever, the switch may provide a signal to the controller that may indicate the position of the lever and / or the readiness of a dose of medication for the user. The signal may be time-stamped and stored in memory. The controller and switch may also be configured to switch or transition the electronic module between multiple power states, which may be used to manage power consumption from the power source.
[0008] When the lever is moved from the first position to the second position by a user for the first time (e.g., after purchase and before the user's first use of the device), the lever may be configured to engage the switch, transitioning the electronic module from an off state to an active state and causing the electronic module to detect an inhalation by the user through the mouthpiece. Thereafter, the electronic module may be configured not to return to the off state after the lever is first moved from the first position to the second position by the user (e.g., the inhalation device may not return to the off state again throughout its lifecycle). The electronic module may be configured to start an internal counter upon transitioning from the off state. The electronic module may be configured to timestamp the detected inhalation or lever movement based on the internal counter.
[0009] The lever may be configured to advance a dose of medication on the flexible strip when the lever is moved from a first position to a second position. Furthermore, in some examples, the body may include a mouthpiece cover, and the lever may be part of the mouthpiece cover. For example, the lever may be configured to move from a first position to a second position when the mouthpiece cover is moved from a closed position to an open position to expose the mouthpiece. Furthermore, in some examples, the body may include two or more flexible strips for medication, each of which may include a different medication. Thus, in such examples, the lever may be configured to advance multiple flexible strips when the lever is moved from a first position to a second position, such that medication from each of the flexible strips is available to the user through the mouthpiece.
[0010] When the electronic module is in an active state, the electronic module may be configured to perform at least one of the following: measure one or more air pressures within the inhaler after the lever is moved from a first position to a second position; determine an inhalation parameter based on the measured at least one air pressure; store the inhalation parameter in a local memory; notify an external device; and transmit the inhalation parameter to the external device. The electronic module may be configured to be in a sleep state when not in an off state or an active state. The electronic module may be configured to change from an active state to a sleep state when the electronic module determines that one or more air pressure measurements received from the pressure sensor do not fall within a predetermined range for a predetermined time, which may be based on an internal counter. The electronic module may be configured to store a timeout event and an associated timestamp when the lever is moved from a first position to a second position and one or more air pressure measurements do not fall within a predetermined range within a predetermined time.
[0011] The sensor system of the electronic module may include a pressure sensor that may measure at least one air pressure within the inhaler after the lever is moved from the first position to the second position. The pressure sensor may be configured to take measurements for a predetermined period of time or until a predetermined event is detected. The electronic module may include a processor configured to determine one or more inhalation parameters (e.g., airflow metrics) based on the at least one measured air pressure.
[0012] Inhalation parameters may include peak flow rate, average flow rate, time to peak flow rate, inhaled volume, inhalation duration, etc. Inhalation parameters may indicate the quality or strength of a user's inhalation and, therefore, the extent to which a full dose of medication has been delivered. Inhalation parameters may also indicate a patient's technique when using an inhalation device. For example, inhalation parameters may indicate whether a patient is inhaling through or exhaling into the device and / or whether a portion of the flow path is blocked or occluded. Inhalation parameters may be time-stamped and stored in memory. The electronic module may be configured to communicate some or all of the data generated, processed, and / or stored by the electronic module to an external device, such as a smartphone. The external device may include software for processing the received data and displaying information indicative of, among other things, the user's compliance and / or adherence with the inhalation device. [Brief explanation of the drawings]
[0013] FIG. 1A is a perspective view of an exemplary inhalation device.
[0014] FIG. 1B is a front perspective view of the exemplary inhalation device of FIG. 1A.
[0015] FIG. 2A is an internal cross-sectional view of the exemplary inhalation device of FIG. 1A.
[0016] FIG. 2B is an internal cross-sectional perspective view of the exemplary inhalation device of FIG. 1A.
[0017] 3A-D are perspective views of the inhalation device of FIG. 1A as the cover is moved from a closed position to an open position.
[0018] FIG. 4 is an exploded perspective view of the exemplary inhalation device of FIG. 1A.
[0019] FIG. 5 is a perspective, internal cross-sectional view of the inhalation device of FIG. 1A with an integrated electronic module.
[0020] 6A and 6B include a flowchart illustrating an example process for transitioning between one or more power states and / or operational modes associated with the inhalation device of FIG. 1A.
[0021] FIG. 7 is a diagram of an exemplary system including the inhalation device of FIG. 1A.
[0022] FIG. 8 is a diagram of an exemplary pressure profile for the inhalation device of FIG. 1A.
[0023] FIG. 9 is an exemplary flow chart of the various states of the indicator of the inhalation device of FIG. 1A.
[0024] [Detailed explanation] This disclosure describes devices, systems, and methods for sensing, tracking, and / or processing usage conditions and parameters associated with a medication delivery device. The devices, systems, and methods are described in connection with a breath-actuated inhalation device for delivering medication to a user's lungs. However, the described solutions are equally applicable to other medication delivery devices, such as syringes, metered-dose inhalers, nebulizers, transdermal patches, or implantables.
[0025] Figure 1A is a perspective view of an exemplary inhalation device 400. Figure 1B is a front perspective view of the exemplary inhalation device 400. Figure 2A is a cross-sectional interior view of the exemplary inhalation device 400. Figure 2B is a cross-sectional interior perspective view of the exemplary inhalation device 400 without the flexible strip 401 installed therein. Figures 3A-D are perspective views of the inhalation device 400 when the cover 491 is moved from a closed position to an open position. Figure 4 is an exploded perspective view of the exemplary inhalation device 400.
[0026] The inhalation device 400 may include a flexible strip 401 attached to its interior. The flexible strip 401 may define a plurality of pockets 402, each containing an inhalable dose of medicament in powder form. The strip 401 may include a base sheet 403 in which blisters are formed to define the pockets 402, and a lid sheet 44, the lid sheet being hermetically sealed to the base sheet 403 except in the area of the blisters so that the lid and base sheets can be peeled apart. The sheets are sealed to each other over their entire width except for their front end portions, which are preferably not sealed to each other at all. The lid sheet and base sheet are each preferably formed from a plastic / aluminum laminate, and the lid sheet and base sheet are preferably adhered to each other by heat sealing. By way of example, the lidding material may be a laminate of 50 gsm bleached kraft paper / 12 micron polyester (PETP) film / 20 micron soft temper aluminum foil / 9 gsm vinyl peelable heat seal lacquer (sealable to PVC) and the substrate may be a laminate of 100 micron PVC / 45 micron soft temper aluminum foil / 25 micron oriented polyamide. The lacquer of the lidding material is sealed to the PVC layer of the base material to provide a peelable seal between the lid sheet and the base sheet.
[0027] The strip 401 may include elongated pockets extending transversely to the length of the strip. The elongated pockets may allow a large number of pockets to be provided within a given strip length. A strip may include, for example, 60 or 100 pockets, although it will be understood that a strip may have any suitable number of pockets.
[0028] The inhalation device 400 is configured to receive a flexible strip 401. The lid sheet 404 has a loop 404a formed at its distal end for engagement over a post 471a extending upward from a toothed wheel 471. The base sheet has a distal portion 403a of reduced width for engagement within a slot 470a formed in a base take-up wheel 470. The distal ends of the base sheet and lid sheet do not have to be sealed to one another.
[0029] The inhalation device 400 may include a body 410. The body 410 may include a base 410a and a top 410b, both of which are generally circular. When the device 400 is assembled, the base and top snap together. The body defines a single internal chamber that houses the strip 401 and also houses a wheel 414 for winding up the used portion of the lid sheet 404, a base take-up wheel 470, and an indexing wheel 416 (and, for example, an electronic module as described herein). The indexing wheel 416 is hollow and houses an indexing ratchet wheel 422 therein. All wheels may be mounted within the chamber defined by the body and capable of rotational movement relative thereto. A pawl 470b is attached to the body 410 and engages with the teeth of the base take-up wheel 470 to prevent the wheel from moving counterclockwise, thus ensuring that the strip 401 can only advance forward through the device.
[0030] The lid take-up wheel 414 may be formed of two portions: a toothed wheel 471 having teeth 472 and a shaft 473; and a foldable wheel 474 having a hollow central shaft 475 and a plurality of resilient arms 476 (e.g., eight such arms as shown) each extending at an angle to a radius from the central shaft 475. The toothed wheel 471 has lugs 477 that may engage corresponding notches in the shaft 475 so that the wheels 471 and 474 rotate as a unit. The hollow indexing wheel 416 has external teeth 478 that mesh with the teeth of the base take-up wheel 470 and the wheels 471. Ratchet teeth 479 are formed on the inner wall of the indexing wheel 416, and the indexing ratchet wheel 422 has two pawls 480 that engage with the ratchet teeth 479.
[0031] The inhalation device 400 may include a manifold 486. The manifold 486 may provide communication between a chamber in the body 410 and the mouthpiece 420. The manifold 486 may include a powder outlet 419 and a passageway 487, for example, to allow the used lid strip 404 to pass to the foldable wheel 474. The powder outlet 419 may provide fluid communication between the mouthpiece 420 and a dose of medicament on the flexible strip 401 (e.g., so that a user can inhale a dose of medicament through the mouthpiece 420). A roller 488 may be provided to guide the strip 404 into the passageway 487.
[0032] The inhalation device 400 may also include a lever 424. The lever 424 may define an arcuate wall 481 having a finger tab 482 and an arm 483 extending inwardly from the wall 481 and carrying an arcuate row of teeth 484 at its end. The lever 424 may be pivotally mounted to the center of the base 410a for movement about an axis at the center of the pitch circle of the teeth 484, which mesh with teeth 485 on the indexing ratchet wheel 422. The lever 424 may be configured such that before actuation of the lever 424, the arcuate wall 481 covers the powder outlet 419, and after actuation of the lever 424, the lever 424 is in an “open” position where the arcuate wall 481 no longer covers the powder outlet 419 and / or the flexible strip 401 is advanced, preparing a dose of medication for delivery to a user.
[0033] The inhalation device may include a dose monitoring ring 489 having teeth 490. The dose monitoring ring 489 may be rotatably disposed within the base 410a of the body. On its underside, it has indicia (not visible in the drawings) that are visible to the user through a window 494 in the body 410. The window is visible both when the cover 491 is closed and when it is open. The indicia indicate, either accurately or approximately, the number of doses remaining (e.g., or the number of doses used). The ring 489 is rotated by its teeth 490 engaging with the teeth 478 of the index wheel.
[0034] The inhalation device 400 may include a cover 491. The cover 491 may be pivotally mounted on the body 410 by lugs 492 on the top 410b of the body and corresponding lugs 493 on the base 410a of the body. The cover 491 may be pivotable between an open position in which the mouthpiece is exposed and a closed position in which the mouthpiece is not exposed, as described herein. Additionally, moving the cover 491 from the closed position to the open position may expose the lever 424 for actuation by the user. The cover 491 may be rotatable about the periphery of the body 410, which may be circular or oval.
[0035] Actuating lever 424 can advance flexible strip 401, preparing a dose of medication for the user. For example, in operation, a user may move cover 491 to its open position and then press finger tab 482 of lever 424 (e.g., actuating lever 424, causing lever 424 to pivot). Actuating lever 424 rotates indexing ratchet wheel 422, which, via pawl 480, also rotates indexing wheel 416. Rotation of indexing wheel 416 causes rotation of both base take-up wheel 470 and lid take-up wheel 414, thus peeling the base and lid sheets apart a sufficient distance to expose the unopened pocket 402 opposite the end of powder outlet 419 in manifold 486. The patient can then inhale through mouthpiece 420.
[0036] Successive stages of the device's operation are shown in Figures 3A-3D. The inhalation device 400 may be in its closed position in Figure 3A. At this stage, the finger tab 482 of the lever 424 is in a recess 482b formed in the body 410 (as can be seen more clearly in Figures 3B and 3C, for example). The cover 419 may be held stationary when the body 410 is rotated counterclockwise, and a recess 410c is provided around the body to allow the user to insert a finger for this purpose. The device 400 is thus moved to the partially open position shown in Figure 3B. During this process, the lever 424 remains stationary relative to the cover 491. This is achieved by a resilient arm 424a provided inside the lever 424, the tip 424b of which engages in a recess 491a in the cover 491. The arm 424a is attached to the lever 424 via a cylindrical member 424c. As seen in Figure 3A, arm 424a extends counterclockwise from member 424c through an arc of approximately 90°. Cylindrical member 424c is guided within an arcuate slot 410d formed in body 410. Slot 410d extends through an arc of approximately 180°, and in Figure 3A, member 424c is shown approximately midway along its length. In Figure 3B, it is shown at one end.
[0037] The user may continue to rotate body 410 from the position shown in FIG. 3B to the position shown in FIG. 3C. During this further rotation, tip 424b of arm 424a pops out of recess 491a. This occurs because, with member 424c at one end of slot 410d, the movement of body 410 carries member 424c with it in a counterclockwise direction, thus forcing arm 424a to move counterclockwise as well. The user then moves lever 424 by pressing finger tab 482, causing counterclockwise rotation through the position shown in FIG. 3C to the position shown in FIG. 3D, where finger tab 482 re-enters recess 482b. The steps described so far expose mouthpiece 420 and open a new blister on flexible strip 401. Device 400 is thus ready for the user to inhale. After use, body 410 is rotated clockwise, and lever 424 moves with the body, returning the device to the position shown in FIG. 3A.
[0038] As more lid sheet is wound onto the wheel 474, the arms 476 may gradually deflect inward, the effect of which is to gradually reduce the inner diameter of the wound lid sheet reel while keeping the outer diameter substantially constant.
[0039] 5 is a perspective, internal cross-sectional view of the inhalation device 400 with the electronic module 120 integrated therein and without the flexible strip 401 disposed therein. The electronic module 120 may be contained within a cavity 450 that exists between an outer wall 452 surrounding the base take-up wheel 470 and an inner wall 454 of the base 410a. Although positioned within the recess 450, it will be understood that the electronic module 120 may be integrated anywhere within the cavity of the inhalation device 400.
[0040] The electronic module 120 may include a printed circuit board (PCB) assembly 122, a switch (not shown), and a power source (e.g., a battery 126). The PCB assembly 122 may include surface-mounted components such as a sensor system 128, wireless communication circuitry 134, a switch, and one or more indicators, such as one or more light-emitting diodes (LEDs) 132. Furthermore, it should be noted that a portion of the manifold 486 has been removed from the inhalation device 400 of FIG. 5 to more easily view the electronic module, and more specifically, the sensor system 128. While a portion of the manifold 486 is not shown in the inhalation device 400 of FIG. 5, the inhalation device 400 of FIG. 5 may actually include the entire manifold 486, as shown, for example, in FIG. 2B. For example, the sensor system 128 may reside behind a portion of the manifold and be in fluid communication with the powder outlet 419.
[0041] The electronic module 120 may include a controller (e.g., a processor) and / or memory. The controller and / or memory may be physically separate components from the PCB 122. Alternatively, the controller and memory may be part of a separate chipset mounted on the PCB 122; for example, the wireless communication circuit 134 may include the controller and / or memory for the electronic module 120. The controller of the electronic module 120 may include a microcontroller, a programmable logic device (PLD), a microprocessor, an application specific integrated circuit (ASIC), a field programmable gate array (FPGA), or any suitable processing device or control circuit. The PCB 122 may be flexible, for example, so that it can reside within the cavity 450 of the inhalation device 400.
[0042] The controller may access information from and store data in memory. The memory may include any type of suitable memory, such as non-removable and / or removable memory. Non-removable memory may include random access memory (RAM), read-only memory (ROM), a hard disk, or any other type of memory storage device. Removable memory may include a subscriber identity module (SIM) card, a memory stick, a secure digital (SD) memory card, etc. The memory may be internal to the controller. The controller may also access and store data from memory not physically located within the electronic module 120, such as on a server or smartphone.
[0043] The sensor system 128 may include one or more sensors, including, for example, one or more pressure sensors. The one or more pressure sensors may include a barometer sensor (e.g., an air pressure sensor), a differential pressure sensor, an absolute pressure sensor, etc. The sensors may employ microelectromechanical systems (MEMS) and / or nanoelectromechanical systems (NEMS) technology. The sensor system 128 may be configured to provide instantaneous pressure values to the controller of the electronic module 120 and / or to provide aggregated pressure values over time. The sensor system 128 may be external to the flow path of the inhalation device 400 (e.g., from the mouthpiece 420, through the powder outlet 419, across the manifold 486). Alternatively, the sensor system 128 may be internal to the flow path of the inhalation device 400.
[0044] As mentioned above, in some examples, the sensor system 128 may include an air pressure sensor. Thus, the sensor system 128 may be configured to measure multiple air pressures within the inhalation device 400. It will be appreciated that the air pressure within the inhalation device 400 may be the same as or close to the air pressure outside the inhalation device 400 when the inhalation device 400 is not in use. However, when a user inhales through the mouthpiece 420, the user's inhalation may decrease the air pressure within the inhalation device 400. Conversely, exhaling into the mouthpiece 420 may increase the air pressure within the inhalation device 400. In both cases, the air pressure within the inhalation device 400 may be different from the air pressure outside the inhalation device 400. Thus, a specific parameter or metric related to inhalation or exhalation may be determined by comparing the changes in air pressure resulting from inhalation or exhalation.
[0045] The switch may be actuated (activated) by one or more components of the inhalation device 400. For example, the switch may be actuated when the lever 424 is moved from a closed position to an open position, e.g., to expose the powder outlet 419 and / or to prepare a dose of medication. For example, the switch may be located on the PCB 122 and on the exterior surface of the manifold 486 such that the arcuate wall 481 of the lever 424 activates the switch when actuated by a user. For example, the switch may be depressed when the arcuate wall 481 covers the powder outlet 419 (e.g., when the lever 424 is in the closed position) and released when the user presses the finger tab 482 of the lever 424 to move it (e.g., pivot the lever 424 to the open position), exposing the powder outlet 419 and / or to prepare a dose of medication. Releasing the switch may activate the switch. Although described in connection with actuating the lever 424, the switch may be actuated using other components of the inhalation device 400. For example, the switch may be actuated by movement of the mouthpiece cover 491, e.g., whereby the switch is not actuated when the mouthpiece cover 491 is closed, but is actuated by opening the mouthpiece cover 491.
[0046] The controller of the electronic module 120 may receive signals corresponding to the pressure measurements from the sensor system 128. The controller may use the signals received from the sensor system 128 to calculate or determine one or more inhalation parameters (e.g., peak flow rate, time to peak flow rate, inhaled volume, inhalation duration, etc.). The inhalation parameters (e.g., airflow metrics) may indicate a profile of airflow through the flow path of the inhalation device 400. For example, if the sensor system 128 records a pressure change of 0.393 kilopascals (kPA), the electronic module 120 may determine that this change corresponds to an airflow rate of approximately 40 liters per minute (Lpm) through the flow path. Table 1 shows example airflow rates based on various pressure measurements. It will be understood that the airflow rates and profiles shown in Table 1 are merely exemplary, and that the determined flow rate may depend on the size, shape, and design of the inhalation device 400 and its components. Additionally, FIG. 8 is a diagram of an example pressure profile for the inhalation device of FIG. 1A. [Table 1] TIFF0007620595000001.tif84166
[0047] As described above, the controller of the electronic module 120 may receive signals corresponding to the pressure measurements from the sensor system 128 and, in response, calculate or determine one or more inhalation parameters. The inhalation parameters may include one or more of the following: average inhalation / exhalation flow rate, peak inhalation / exhalation flow rate (e.g., maximum inhalation received), inhalation / exhalation volume, time to peak inhalation / exhalation, and / or inhalation / exhalation duration. The inhalation parameters may also indicate the direction of flow through the flow path. That is, a negative change in pressure may correspond to inhalation from the mouthpiece 420, and a positive change in pressure may correspond to exhalation into the mouthpiece 420. When calculating the inhalation parameters, the electronic module 120 may be configured to remove or minimize any distortions introduced by environmental conditions. For example, the electronic module 120 may "zero out" to account for changes in air pressure before or after calculating the inhalation parameters. One or more pressure measurements and / or inhalation parameters may be time-stamped and stored in the memory of the electronic module 120.
[0048] The controller of the electronic module 120 may compare the signals received from the sensor system 128 and / or the determined inhalation parameters to one or more thresholds or ranges, for example, as part of an evaluation of how the inhalation device 400 is being used and / or whether its use will result in delivery of a full dose of medication. For example, if the determined inhalation parameters correspond to an inhalation having an airflow rate below a particular threshold, the electronic module 120 may determine that there was no inhalation or that there was an insufficient inhalation through the mouthpiece 420 of the inhalation device 400. If the determined inhalation parameters correspond to an inhalation having an airflow rate above a particular threshold, the electronic module 120 may determine that there was excessive inhalation through the mouthpiece 420. If the determined inhalation parameters correspond to an inhalation having an airflow rate within a particular range, the electronic module 120 may determine that the inhalation is “good” or will result in delivery of a full dose of medication. As mentioned above, the electronic module 120 may include indicators, such as LEDs. The indicators may be configured to provide the user with feedback regarding their use of the inhalation device 400. Thus, in one example, the LED 132 may illuminate or change color when the inhalation parameters correspond to a good inhalation or to no inhalation. The inhalation parameters may also be calculated and / or evaluated (e.g., partially or fully) via an external device.
[0049] More specifically, the wireless communication circuitry 134 of the electronic module 120 may include a transmitter and / or receiver (e.g., a transceiver) as well as additional circuitry. For example, the wireless communication circuitry 134 may include a Bluetooth chipset (e.g., a Bluetooth Low Energy chipset), a ZigBee chipset, a Thread chipset, etc. Thus, the electronic module 120 may wirelessly provide data such as pressure measurements, inhalation parameters, and / or other conditions related to the use of the inhalation device 400 to an external device, including a smartphone. The external device may include software for processing the received information and for providing compliance and adherence feedback to the user of the inhalation device 400 via a graphical user interface (GUI).
[0050] The battery 126 may provide power to the components of the PCB 122. The battery 126 may be any suitable power source for powering the electronic module 120, such as, for example, a coin cell battery. The battery 126 may be rechargeable or non-rechargeable. The battery 126 may be housed by a battery holder (not shown). The battery holder may be secured to the PCB 122, an inner wall 454 of the base 410a, and / or the like so that the battery 126 maintains continuous contact with the PCB 122 and / or is electrically connected to the components of the PCB 122. The battery 126 may have a specific battery capacity that may affect the lifespan of the battery 126. As described further below, the distribution of power from the battery 126 to one or more components of the PCB 122 may be managed to ensure that the battery 126 can power the electronic module 120 for the shelf life (useful life) of the inhalation device 400 and / or the medication contained therein.
[0051] Although not shown, in one or more examples, the inhalation device 400 may include multiple flexible strips for medication. For example, the inhalation device 400 may include two flexible strips for two different types of medication, and the lever 424 may be configured to advance the flexible strips for both medications (e.g., simultaneously or sequentially). Furthermore, actuation of the lever 424 may advance the flexible strips for both medications such that the base sheet and the lid sheet of each flexible strip are pulled apart, exposing an unopened pocket from each flexible strip. The powder medication released from the pockets of each flexible strip may be delivered to a mixing chamber within the body of the inhalation device for inhalation by the patient through the mouthpiece 420. Thus, the inhalation device 400 may provide different types of medications that are stored separately but released and delivered to the patient as a single combined medication.
[0052] It will further be appreciated that the inhalation device 400 may include flexible strips for any number of medicaments, and that, for example, the inhalation device 400 may be configured so that pockets from the flexible strips for any number of medicaments are opened in one or more stages (e.g., through the use of a single actuator, such as by a single actuation of the lever 424). For example, the inhalation device 400 may be configured so that an actuator (e.g., a single actuator) advances the first and second medicament strips to open their respective pockets and combine the medicaments therein, and further advances one or more additional medicament strips to open their respective pockets and combine the medicaments from the additional strips with the combined medicaments from the first and second strips. Thus, the inhalation device 400 may be configured to combine any number of types of medicaments into a single dose, potentially in two or more stages, while storing each type of medicament on a separate flexible strip.
[0053] It will further be appreciated that in some examples, inhalation device 400 may provide a single mechanism for exposing mouthpiece 420 from beneath mouthpiece cover 491, exposing powder outlet 419, preparing a dose of medicament (e.g., by advancing one or more medicament flexible strips), and / or actuating switches in electronic module 120 to operate (e.g., switch on / off) one or more components of electronic module 120 (e.g., changing the power state of electronic module 120). For example, mouthpiece cover 491 and / or lever 424 may be such a mechanism. Thus, in some examples, the inhalation device 400 may be configured such that movement of the mouthpiece cover 491 from a closed position to an open position causes the mouthpiece 420 to be exposed, along with one or more powder outlets 419 being exposed, a dose of medicament being prepared (e.g., one or more flexible strips for the medicament being advanced), and / or a switch in the electronic module 120 being actuated (e.g., changing the power state of the electronic module 120). In such examples, the inhalation device 400 may not include the lever 424, as the function of the lever 424 may be performed by the mouthpiece cover 491. Alternatively, for example, the lever 424 may be part of the mouthpiece cover 491, such that the lever 424 moves when the mouthpiece cover 419 is moved to expose the mouthpiece 420. It will further be understood that in some examples, any other component of the inhalation device 400 (e.g., lever 424) may be configured to cause any combination of exposing the mouthpiece 420 from under the mouthpiece cover 491, exposing the powder outlet 419, preparing a dose of medication (e.g., by advancing one or more flexible medication strips), and / or activating a switch in the electronic module 120.
[0054] The electronic module 120 may have multiple power states, each having a respective power consumption level. For example, the electronic module 120 may be configured to operate in a system off state, a sleep state, and / or an active state. The system off state may be characterized by very little or no power consumption, while the sleep state may be characterized by greater power consumption than the off state, and the active state may be characterized by greater power consumption than the sleep state. While the electronic module 120 is in the active state, the electronic module may operate in one or more modes, such as a measurement mode, a data storage / data processing mode, a notification mode, and / or a connection mode. It will be understood that the electronic module 120 may operate in more than one mode at a time (e.g., the modes may overlap). For example, as described in more detail below, the electronic module 120 may operate in the measurement mode and the data storage / data processing mode, either discretely or simultaneously. That is, electronic module 120 may perform all measurements before processing / storing the data, or electronic module 120 may perform additional measurements while simultaneously performing data processing / storage (e.g., electronic module 120 may switch between measurement mode and data storage / data processing mode before either is completed).
[0055] In the system off state, the electronic module 120 may consume a minimal amount of power relative to other power states (e.g., sleep and active states). In particular, the electronic module 120 may use a minimal amount of power to monitor a particular pin (or pins) on the controller, while other components such as the sensor system 128, wireless communication circuitry 134 (e.g., Bluetooth radio), and memory may be powered down. A pin on the controller may be electrically connected to a switch such that actuation of the switch may result in a particular reference signal on the pin. The reference signal may cause the controller to transition from the off state.
[0056] The off state may be the initial state of the electronic module 120 after the inhalation device 400 is assembled or manufactured. Thus, the electronic module 120 may be in the off state before the inhalation device 400 is delivered to a user and / or before the lever 424 is moved from the closed position to the open position (e.g., before the first use of the inhalation device 400 by a user), which movement of the lever 424 may, for example, expose the powder outlet 419 and / or prepare an initially opened dose of medication. Furthermore, once the lever 424 is actuated for the first time, the electronic module 120 may not subsequently return to the off state. In some examples, the controller may start its internal clock (e.g., an internal counter) when the electronic module 120 first exits the off state, and any timestamp data generated by the electronic module 120 may be a relative time based on the controller's internal clock. Thus, the internal clock may function as a counter that starts when the electronic module 120 exits the off state. Alternatively or additionally, the controller may include an internal system clock that knows the actual time (e.g., 4:05 PM EST on November 18, 2017), and the timestamp data may include the actual time. In such an example, the controller may use power in the off state to run its real-time clock oscillator and to update its system clock.
[0057] As described above, while electronic module 120 is in the active state, electronic module 120 may operate in one or more modes, such as a measurement mode, a data storage / data processing mode, a notification mode, and / or a connection mode. In the sleep state, the switch and controller may continue to receive power from battery 126, and the controller may keep its oscillator running and periodically update its system clock (e.g., may continue to increment an internal counter that was started when electronic module 120 first came out of the off state). In some examples, the controller may periodically update the system clock every 250 μs.
[0058] Additionally, while in the sleep state, the controller may continue to receive power from the battery 126 to control one or more additional components of the electronic module 120. For example, during notification mode, the controller may periodically power on the communication circuitry 134 to wirelessly “advertise” to external devices that data is stored in the inhalation device 400 and available for wireless download. The communication circuitry 134 may transmit notification packets at any interval suitable for managing the power consumption of the electronic module 120 when in the sleep state (e.g., compared to the intervals at which packets may be transmitted during the active state). For example, notification packets may be transmitted every 10 seconds when the electronic module 120 is operating in the sleep state. It will be understood that the electronic module 120 may spend more time in the sleep state than in any of the other power states. Thus, at a given notification rate, the electronic module 120 may consume the most power in the sleep state over the life of the inhalation device 400.
[0059] In measurement mode, the controller of the electronic module 120 may power on the sensor system 128. The controller may cause the sensor system 128 to take pressure measurements for a predetermined period of time (e.g., up to 60 seconds) until the lever 424 is closed (e.g., closed to cover the powder outlet 419) and / or until no change in pressure is detected. The controller may turn off one or more components of the electronic module 120 while the sensor system 128 is taking pressure measurements to further conserve power. The sensor system 128 may sample the pressure at any suitable rate. For example, the sensor system 128 may have a sampling rate of 100 Hz, and therefore a cycle time of 10 milliseconds. The sensor system 128 may generate a measurement complete interrupt after a measurement cycle is complete. The interrupt may "wake" the controller or cause the controller to turn on one or more components of the electronic module 120. For example, after or while the sensor system 128 samples a pressure measurement, the controller may process and / or store the pressure measurement data and power off the sensor system 128 once the measurement is complete.
[0060] In the data storage / data processing mode, the controller may power on at least a portion of the memory in the electronic module 120. The controller may process values from the sensor system 128 to determine inhalation parameters and store the inhalation parameters in memory. The controller may also compare the values and / or inhalation parameters to one or more thresholds or ranges to assess how the inhalation device is being used (e.g., whether the pressure value corresponds to no inhalation, a "good" inhalation, exhalation, etc.). Depending on the results of the comparison, the controller may activate an indicator to provide feedback to the user of the inhalation device 400. As described above, the electronic module 120 may operate in the measurement mode and the data storage / data processing mode simultaneously.
[0061] In notification mode, the controller may power on the communications circuitry 134 (e.g., Bluetooth radio) to notify external devices that data is available from the inhalation device 400 and ready for wireless download. Notification packets may be sent at any interval and for any duration suitable for managing power consumption of the electronic module 120 during notification mode. For example, the communications circuitry 134 may send a notification packet every 100 milliseconds (ms) for three minutes. It will be further understood that the notification rate may vary based on the specific conditions of the electronic module 120. For example, the notification rate may be “fast” after measurements and data processing / storage have occurred (e.g., packets are sent every 100 ms), while the notification rate may be “slow” (e.g., packets are sent every 10 seconds) when the electronic module 120 is transitioning from a sleep state to another state (e.g., not immediately after measurements and data processing / storage have occurred).
[0062] In the connected mode, the communications circuitry 134 and memory may be powered on, and the electronic module 120 may be “paired” with an external device, such as a smartphone. The controller may retrieve data from memory and wirelessly transmit the data to the external device. The controller may retrieve and transmit all of the data currently stored in memory. The controller may also retrieve and transmit a portion of the data currently stored in memory. For example, the controller may determine which portions have already been transmitted to the external device and then transmit the portions not previously transmitted. Alternatively, the external device may request specific data from the controller, such as any data collected by the electronic module 120 after a specific time or since the last transmission to the external device. The controller may retrieve specific data, if any, from memory and transmit the specific data to the external device.
[0063] The electronic module 120 may transition between power states and / or operating modes based on certain conditions or events, such as the position of the lever 484, the position of the mouthpiece cover 491, and / or the passage of a predetermined period of time. For example, the mouthpiece cover 491 may be closed and the electronic module 120 may be in an off state or a sleep state. After the cover 491 is opened, the lever 424 may be actuated (e.g., moved from a closed position to an open position to expose the powder outlet 419 and prepare a dose of medication), which may activate a switch. For example, as described above, the switch may be located on the exterior surface of the manifold 486 such that the arcuate wall 481 of the lever 424 activates the switch when actuated by a user. For example, the switch may be depressed when the arcuate wall 481 covers the powder outlet 419 and released when the user presses the finger tab 482 of the lever 424 to move it (e.g., pivot the lever 424) to expose the powder outlet 419 and / or prepare a dose of medication. Releasing the switch may actuate the switch. Although described with reference to actuating the lever 424, the switch may be actuated using other components of the inhalation device 400. For example, the switch may be actuated by movement of the mouthpiece cover 491, e.g., the switch may not be actuated when the mouthpiece cover is closed, but may be actuated by the mouthpiece cover 491 being opened. Actuating the switch may transition the electronic module 120 from one state (e.g., a system off state or a sleep state) to another state (e.g., an active state). Additionally, actuation of the switch may cause the electronic module 120 to begin operating in one or more operating modes, such as a measurement mode and / or a data storage / data processing mode. For example, Figures 6A-B show an example flowchart 200 illustrating an example process for transitioning between one or more power states and / or operating modes associated with the inhalation device 400.
[0064] 6A-B illustrate an example procedure 200 for transitioning between one or more power states and / or operating modes associated with an inhalation device 400. While described with reference to an inhalation device 400, any inhalation device may perform procedure 200. The electronic module 120 of the inhalation device 400 may be in an off state at 202 when procedure 200 begins. The mouthpiece cover 491 may be in a closed position, and the user may not have initially actuated the lever 424 when the electronic module 120 is in the off state at 202. As described herein, the off state may be characterized by little or no power consumption by the electronic module 120. At 204, the electronic module 120 may determine whether the lever 424 has been moved from a first, closed position to a second, open position (e.g., whether the lever 424 has been actuated). If the electronic module 102 determines that the lever 424 has not been moved to the open position, the electronic module 120 may remain in the off state at 202 .
[0065] If the electronic module 120 determines at 204 that the lever 424 has been moved to the open position, the electronic module 120 may enter a system active state at 206. The active state may be characterized by greater power consumption than the off state (e.g., and sleep state). When in the active state, the electronic module 120 may operate in one or more modes, such as a measurement mode, a data storage / data processing mode, a notification mode, and / or a connection mode. For example, actuation of the lever 424 may actuate a switch. Actuating the switch may transition the electronic module 120 from the off state to the active state. Additionally, actuation of the lever 424 may advance the flexible strip 401, preparing a dose of medication for use in inhalation.
[0066] While in the active state and after lever 424 is actuated, electronic module 120 may enter measurement mode at 208. During measurement mode, electronic module 120 may power on sensor system 128 and cause sensor system 128 to take pressure measurements for a predetermined period of time (e.g., up to 60 seconds) and / or until mouthpiece cover 491 is closed or no change in pressure is detected.
[0067] In some examples, the electronic module 120 may remain in measurement mode until a pressure measurement cycle is completed. The pressure measurement cycle may continue for a predetermined period of time and / or until a specific event is detected. For example, the pressure measurement cycle may continue for up to 60 seconds, even if the mouthpiece cover 491 is closed and / or the lever 424 is released from the switch. Alternatively, the pressure measurement cycle may continue for up to 60 seconds, or until the mouthpiece cover 491 is closed, or until no change in pressure is detected for 10 seconds, whichever comes first. It will be understood that the aforementioned conditions are merely examples, and any suitable criteria may be used.
[0068] At 212, the electronic module 120 may enter a data processing / data storage mode. During the data processing / data storage mode, the electronic module 120 may power on at least a portion of the memory within the electronic module 120. The electronic module 120 may process values from the sensor system 128 to determine inhalation parameters / metrics and store the inhalation parameters / metrics in memory. The electronic module 120 may also compare the measurements and / or inhalation parameters / metrics to one or more thresholds or ranges to assess how the inhalation device is being used (e.g., whether the pressure value corresponds to no inhalation, a "good" inhalation, exhalation, etc.). Depending on the results of the comparison, the electronic module 120 may activate an indicator to provide feedback to the user of the inhalation device 400.
[0069] Although not illustrated by procedure 200, electronic module 120 may operate in a measurement mode and a data storage / data processing mode simultaneously. For example, electronic module 120 may switch (e.g., periodically switch) between the measurement mode and the data processing / data storage mode. For example, after or while electronic module 120 receives pressure measurements, electronic module 120 may process and / or store the pressure measurement data.
[0070] The electronic module 120 may remain in the data storage / data processing mode for a predetermined period of time to process and store pressure measurements from the sensor system 128. For example, the electronic module 120 may remain in the data storage / data processing mode for up to 60 ms. The electronic module 120 may use, for example, up to 50 ms to process and calculate inhalation parameters from the pressure measurements and up to 10 ms to store the pressure measurements and / or inhalation parameters in memory. Alternatively, the electronic module 120 may remain in the data storage / data processing mode for whatever time it takes the controller to process and store the pressure measurements and / or airflow metrics.
[0071] The electronic module 120 may enter notification mode at 216. For example, the electronic module 120 may enter notification mode after a predetermined period of time for data processing and data storage has elapsed, or after the controller determines that such processing and storage has completed. During notification mode, the electronic module 120 may power on the communication circuitry 134 (e.g., Bluetooth radio) to notify external devices that data is available from the inhalation device 400 and is ready for wireless download. Notification packets may be transmitted at any interval and for any duration suitable for managing power consumption of the electronic module 120 during notification mode. For example, the communication circuitry 134 may transmit a notification packet every 100 milliseconds (ms) for three minutes. It will be understood that the notification rate may vary based on the particular conditions of the electronic module 120. For example, the notification rate may be "fast" (e.g., a packet is sent every 100 ms) after measurements and data processing / storage have occurred (e.g., when transitioning from 212 to 216), while the notification rate may be "slow" (e.g., a packet is sent every 10 seconds) when the electronic module 120 is transitioning out of a sleep state and the lever 424 has not been moved to the open position (e.g., when transitioning from 230 to 216).
[0072] At 218, the electronic module 120 may determine whether the external device is within range. If the external device does not come within a certain range of the electronic module 120 while in notification mode, the electronic module 120 may determine at 220 whether a notification period (e.g., three minutes) has elapsed. The notification period may be a period during which the electronic module 120 continues to notify the external device before changing power states. If the notification period has not elapsed, the electronic module 120 may continue to notify the external device at 216. However, if the notification period has elapsed, the electronic module 120 may transition to a sleep state at 222. The sleep state may be characterized by greater power consumption than the off state but less power consumption than the on state.
[0073] The electronic module 120 may remain in the sleep state for a predetermined amount of time or until the electronic module determines that the lever 424 has been moved from the closed position to the open position. For example, the electronic module 120 may periodically switch between the sleep state and an active notification mode (e.g., a slow notification mode). For example, at 224, the electronic module 120 may determine whether the lever 424 has been moved from the closed position to the open position. If the lever 424 has been moved to the open position, the electronic module 120 may enter the active state at 206. For example, actuation of the lever 424 may actuate a switch. Actuation of the switch may transition the electronic module 120 from the sleep state to the active state.
[0074] If the electronic module 120 determines that the lever 424 remains in the closed position, the electronic module 120 may determine at 230 whether a sleep period (e.g., 10 seconds) has elapsed. If the sleep period has not elapsed at 230, the electronic module 120 may remain in the sleep state and return to 222. However, if the sleep period has elapsed at 230, the electronic module 120 may return to the active notification mode at 216. When the electronic module 120 transitions from 230 to 216, the electronic module 120 may notify at a different rate, possibly a slower rate (e.g., once every 10 seconds instead of once every 100 ms) compared to when the electronic module 120 transitions from 212 to 216. Thus, the electronic module 120 may use less battery power during such a notification mode. Additionally, the electronic module 120 may periodically switch between an active state and a sleep state based on a notification period and a sleep period (eg, while the mouthpiece cover 491 is in the closed position).
[0075] Returning to 218, when an external device (e.g., a smartphone or tablet) comes within a certain range of the electronic module 120 while in notification mode, the electronic module 120 may “pair” with the external device at 226 and enter connection mode. In connection mode, the electronic module 120 may power on the communications circuitry 134 and memory. The electronic module 120 may retrieve data from memory and wirelessly transmit the data to the external device. At 228, the electronic module 120 may determine whether the transmission is complete or whether the external device is out of communication range. If the transmission is not complete and the external device is within communication range, the electronic module 120 remains in connection mode. However, if the transmission is complete or if the external device is out of communication range, the electronic module 120 transitions to a sleep state at 222.
[0076] During the connected mode, electronic module 120 may retrieve and transmit a portion of the data currently stored in memory, or the controller may retrieve and transmit a portion of the data currently stored in memory. For example, the controller may determine which portions have already been transmitted to the external device and then transmit the portions that have not yet been transmitted (e.g., based on an internal counter). Alternatively or additionally, the external device may request specific data from electronic module 120, such as any data collected by electronic module 120 after a specific time or since the last transmission to the external device. Electronic module 120 may retrieve the specific data from memory, if any, and transmit the specific data to the external device.
[0077] Additionally, when connected to an external device, the electronic module 120 may be configured to transmit Bluetooth special interest group (SIG) characteristics to manage access to records stored in the module 120. The Bluetooth SIG characteristics may include one or more of the manufacturer's name of the inhalation device 400, the serial number of the inhalation device 400, the hardware revision number of the inhalation device 400, and / or the software revision number of the inhalation device 400. When connected to an external device, the electronic module 120 may retrieve data from memory and transmit the data to the external device.
[0078] The inhalation device 400 may include a Quick Response (QR) code. The external device may include a camera and a software application for accessing the camera and reading the QR code. The QR code may include a BLE passkey unique to the inhalation device 400. Upon reading or scanning the QR code with the camera, the software application may receive the BLE passkey associated with the device 400 and complete the authentication process, allowing it to communicate with the electronic module 120 using the BLE passkey. If the communication session is subsequently lost, for example because the inhalation device 400 moves out of range, the external device may be configured to automatically pair with the electronic module 120 using the BLE passkey without using the QR code when the inhalation device 400 returns within range.
[0079] When in a connected mode, the inhalation device 400 may transmit inhalation events, inhalation parameters, pressure measurements, mouthpiece cover 491 open or closed events, lever 424 actuation events, error events, inhalation device operating characteristics (e.g., remaining battery life), and / or associated timestamps (e.g., based on internal counters) to an external device. For example, signals generated by the switch, pressure measurements obtained by the sensor system 128, and / or inhalation parameters calculated by the controller of the electronic module 120 may be time-stamped and stored in memory. Such data may indicate various usage parameters associated with the inhalation device 400. For example, as movement of the arcuate wall 481 of the lever 424 transitions the switch between "on" and "off," the controller of the electronic module 120 may record and time-stamp each transition using a signal from the switch. Furthermore, because the transition of the switch between "on" and "off" may correlate with the position of the lever 424 (e.g., a closed position covering the powder outlet 419, or an open / actuated position to open the powder outlet 419 and / or prepare the blister of medication for delivery to the user), the electronic module 120 may be able to detect and track the position of the lever 424 over time. It will be appreciated that the electronic module 120 may be able to sense and track the state of the lever 424 without interfering with the delivery of medication through the flow path of the inhalation device 400.
[0080] The pressure measurements and / or calculated inhalation parameters may indicate the quality or strength of the inhalation from the inhalation device 400. For example, when compared to a particular threshold or range of values, the values and / or metrics may be used to classify the inhalation as a particular type of event, such as a good inhalation event, a low inhalation event, a no inhalation event, or an excessive inhalation event.
[0081] A no-inhalation event may be associated with a pressure measurement and / or inhalation parameter below a certain threshold, such as an airflow rate below 30 Lpm. A no-inhalation event may occur when the user does not inhale through the mouthpiece 420 after opening the mouthpiece cover 491 and between measurement cycles. A no-inhalation event may also occur when the user's inspiratory effort is insufficient to ensure proper delivery of the medication through the flow path, such as when the user's inspiratory effort creates insufficient airflow to aerosolize the medication.
[0082] A low inhalation event may be associated with a pressure measurement and / or inhalation parameters within a particular range, such as an airflow rate between 30 Lpm-45 Lpm. A low inhalation event may occur when a user inhales through the mouthpiece 420 after opening the mouthpiece cover 491 and the user's inhalation effort delivers at least a portion of the dose of medication through the flow path. That is, the inhalation may be sufficient to aerosolize a portion of the medication.
[0083] A successful inhalation event may be associated with a pressure measurement and / or inhalation parameters that exceed a low inhalation event, such as an airflow rate between 45 Lpm-200 Lpm. A successful inhalation event may occur when a user inhales through the mouthpiece 420 after opening the mouthpiece cover 491 and the inhalation effort is sufficient to ensure adequate delivery of the medication through the flow path, such as when the user's inhalation effort produces enough airflow to aerosolize an entire dose of the medication.
[0084] An excessive inhalation event may be associated with pressure measurements and / or inhalation parameters that exceed a good inhalation event, such as an airflow rate exceeding 200 Lpm. An excessive inhalation event may occur when a user's inhalation effort exceeds the normal operating parameters of the inhalation device 400. An excessive inhalation event may also occur when a user's inhalation effort is within normal limits but the device 400 is not properly positioned or held during use. For example, the calculated airflow rate may exceed 200 Lpm if the vent is blocked or obstructed (e.g., by a finger or thumb) while the user is inhaling through the mouthpiece 420.
[0085] It will be appreciated that any suitable threshold or range may be used to classify a particular event. It will further be appreciated that some or all of the events may be used. For example, a no-inhalation event may be associated with an airflow rate of less than 45 Lpm, and a good inhalation event may be associated with an airflow rate between 45 Lpm and 200 Lpm. Thus, a low inhalation event may not be used at all.
[0086] The pressure measurements and / or calculated inhalation parameters may also indicate the direction of flow through the flow passages of the inhalation device 400. For example, if the pressure measurements reflect a negative change in pressure, the measurements may indicate air flowing out of the mouthpiece 420 via the flow passages. If the pressure measurements reflect a positive change in pressure, the measurements may indicate air flowing into the mouthpiece 420 via the flow passages. Thus, the pressure measurements and / or inhalation parameters may be used to determine whether the user is exhaling into the mouthpiece 420, which signals that the user is not using the device 400 properly.
[0087] By time-stamping and storing the signals generated by the switches, the pressure measurements taken by the sensor system 128, and / or the inhalation parameters calculated by the controller of the electronics module 120, the data collected and stored by the electronics module 120 may be used to determine whether the usage parameters are adequate or correct over a given period of time, and thus the data may be indicative of other events, such as over-usage, under-usage, or optimal usage events.
[0088] For example, a user of the inhalation device 400 may be prescribed by a physician to take two doses (two servings) of medication via the inhalation device 400 each day. Additionally, the medication contained in the inhalation device 400 may also be approved (e.g., for safety and regulatory purposes) to be taken no more than eight times each day. An overuse event may occur if the electronic module 120 records more than two successful inhalations in a 24-hour period (i.e., if the actual administration exceeds the number of prescribed doses) and / or if the electronic module 120 records more than eight successful inhalations in a 24-hour period (i.e., if the actual administration exceeds the number of doses approved by regulation). An underuse event may occur if the electronic module 120 records fewer than two successful inhalations in a 24-hour period (i.e., if the actual administration is less than the number of prescribed doses). An optimal use event may occur if the electronic module 120 records two successful inhalations in a 24-hour period (i.e., if the actual administration is less than the number of prescribed doses). It will be appreciated that an optimal usage event may be indicative of a user being adherent. It will further be appreciated that the prescribed dosing schedule and / or maximum approved dosing schedule may depend on the type of medication included in the inhalation device 400. Furthermore, an event may be defined using any suitable number of doses over any suitable period of time, such as two doses per day, 14 doses per week, 60 doses per month, etc.
[0089] The data collected and stored by the electronic module 120 may also be used to calculate the number of doses delivered from the inhalation device 400 and / or to calculate the number of doses remaining on the flexible strip 401. For example, each time a switch is activated via actuation of the lever 424, the signal generated by the switch may be counted as one dose delivery event. Thus, the inhalation device 400 may be considered to have delivered 60 doses when the lever 424 is actuated 60 times. The inhalation device 400 may be configured to store enough medication on the flexible strip 401 to deliver a predetermined total number of doses, such as a total of 200 doses. Thus, the inhalation device 400 may also be considered to have 140 doses remaining after the lever 424 has been actuated 60 times.
[0090] As described above, if a previous dose of medication was not properly administered, no medication will be delivered from the flexible strip 401 when the user actuates the lever 424. It will be appreciated, therefore, that counting the number of doses based on actuation of the lever 424 may not accurately reflect the actual number of doses delivered by the device 400, for example, if the user actuates the lever 424 without inhaling through the mouthpiece 420. Accordingly, other data within the electronic module 120 may be used and / or combined with the signal from the switch to determine the number of doses delivered and / or remaining in the inhalation device 400. For example, a dose may be counted as delivered whenever a calculated inhalation parameter exceeds a threshold or is within a particular range, such as when a successful inhalation event is recorded. By calculating and tracking the number of delivered and / or remaining doses, the electronic module 120 may be configured to identify refill events, which may indicate when the user should consider obtaining a new inhalation device 400.
[0091] The data collected and stored by electronic module 120 may also be used to identify various error conditions related to the operation of module 120. For example, when processing data, electronic module 120 may generate a bad data flag, a data corruption flag, a timestamp error flag, and / or the like. Electronic module 120 may generate a bad data flag when its controller determines that one or more signals received from sensor system 128 are outside of a predetermined range, which may indicate a malfunction of sensor system 128. Electronic module 120 may generate a data corruption flag when a cyclic redundancy check (CRC) of the controller's data does not match that stored in memory, which may indicate a memory malfunction and / or corrupted data in memory. Electronic module 120 may generate a timestamp error flag and cause the controller's system clock to reset when the controller loses electrical connection with battery 126. If the controller's system clock is reset, the controller may restart its clock from the last stored counter value.
[0092] The electronic module 120 (e.g., and / or a mobile application residing on an external device) may also analyze the recorded events over a period of time to identify multiple error events, which may include usage patterns indicative of a user who is not familiar with the proper operation of the inhalation device 400 and therefore may require further training. For example, the electronic module 120 may observe the number of successful inhalation events over a predetermined period of time and / or over a predetermined number of actuations of the lever 424. A multiple error event may occur when a user has had only two successful inhalation events over the past week or six or fewer successful inhalations over the last 12 actuations of the lever 424. It will be understood that the foregoing conditions are merely examples, and any suitable usage pattern may be used to define a multiple error event.
[0093] The data collected and stored by the electronic module 120 may also be used to assess the amount of power remaining in the battery 126. For example, the controller may determine whether there is a low battery event or condition, such as whether the battery has less than a predetermined amount of power remaining (e.g., less than 10%).
[0094] It will be appreciated that the electronic module 120 may process and analyze data stored in memory (e.g., signals generated by the switches, pressure measurements obtained by the sensor system 128, and / or inhalation parameters calculated by the controller of the electronic module 120) to determine usage parameters associated with the inhalation device 400. For example, the electronic module 120 may process the data to identify no-inhale events, low-inhale events, good-inhale events, over-inhale events, and / or exhalation events. The electronic module 120 may also process the data to identify under-use events, over-use events, and optimal use events. The electronic module 120 may further process the data to estimate the number of delivered and / or remaining doses and identify error conditions, such as those associated with a timestamp error flag. The electronic module 120 may inform the user of some or all of the aforementioned usage parameters of the inhalation device 400 using indicators, such as one or more LEDs. As an example, electronic module 120 may illuminate LED 132 to indicate a good inhalation event and may change the color of LED 132 to indicate a poor inhalation event or a no inhalation event. Usage parameters may be indicated to the user via any combination of light sequences and / or light color schemes.
[0095] It will further be appreciated that data stored in the memory of the electronic module 120 (e.g., signals generated by the switches, pressure measurements obtained by the sensor system 128, and / or inhalation parameters calculated by the controller of the electronic module 120) may also be transmitted to an external device, which may process and analyze the data to determine usage parameters associated with the inhalation device 400. Additionally, a mobile application resident on the mobile device may generate feedback for the user based on the data received from the electronic module 120. For example, the mobile application may generate daily, weekly, or monthly reports, provide confirmation of error events or notifications, provide educational feedback to the user, and / or the like.
[0096] 7 is a diagram of an example system 300, which includes an inhalation device 400, an external device (e.g., a mobile device 304), a public and / or private network 306 (e.g., the Internet, a cloud network), a healthcare provider 308, and a third party 310 (e.g., a friend, family member, a pharmaceutical manufacturer, etc.). The mobile device 304 may include a smartphone (e.g., an iPhone® smartphone, an Android® smartphone, or a Blackberry® smartphone), a personal computer, a laptop, a wireless-enabled media device (e.g., an MP3 player, a gaming device, a television, a media streaming device (e.g., Amazon Fire TV, Nexus Player, etc.), etc.), a tablet device (e.g., an iPad® handheld computing device), a Wi-Fi or wireless communication-enabled television, or any other Internet Protocol-enabled device. For example, the mobile device 304 may be configured to transmit and / or receive RF signals via a Wi-Fi communication link, a Wi-MAX communication link, a Bluetooth or Bluetooth Smart communication link, a near field communication (NFC) link, a cellular communication link, a television white space (TVWS) communication link, or any combination thereof. The mobile device 304 may transfer data via public and / or private networks 306 to a healthcare provider 308 and / or one or more third parties 310 (e.g., friends, family, pharmaceutical companies, etc.).
[0097] As described herein, the inhalation device 400 may include communication circuitry 134, such as a Bluetooth radio, for transferring data to the mobile device 304. The data may include signals generated by the switch, pressure measurements obtained by the sensor system 128, and / or inhalation parameters calculated by the controller of the electronics module 120. The inhalation device 400 may receive data from the mobile device 304, such as, for example, program instructions, operating system changes, dosing information, alerts or notifications, receipt acknowledgments, etc.
[0098] The mobile device 304 may process and analyze the data to determine usage parameters associated with the inhalation device 400. For example, the mobile device 304 may process the data to identify no-inhale events, low-inhale events, good-inhale events, over-inhale events, and / or exhale events. The mobile device 304 may also process the data to identify under-use events, over-use events, and optimal use events. The mobile device 304 may further process the data to estimate the number of delivered and / or remaining doses and identify error conditions, such as those associated with timestamp error flags. The mobile device 304 may include a display and software for visually presenting the usage parameters via a GUI on the display.
[0099] As described herein, the inhalation device 400 may include one or more indicators, such as a light-emitting diode (LED) 132. The LED 132 may have multiple colors and / or multiple display modes. For example, the LED 132 may be on, off, flashing, and / or illuminated in multiple colors. The LED 132 may use different flashing patterns. FIG. 9 is an example flowchart of various states of an inhalation device 400 having a single indicator (e.g., the LED 132). At 910, the lever 424 of the inhalation device 400 is closed and the LED 132 is in State 1. For example, the LED 132 may be off in State 1. When the inhalation device 400 detects (e.g., via a switch in the e-module 120) that the lever 424 has been actuated at 915, the LED 132 may transition to State 2 (e.g., change to State 2) at 920. For example, the LED 132 may be illuminated or flashing in State 2. When the inhalation device 400 detects a pressure measurement via the pressure sensor (e.g., at a first threshold), the LED 132 may be in state 3 at 930. For example, the LED 132 may be solid or flashing in state 3. The pressure measurement may indicate (e.g., caused by) the user inhaling medication.
[0100] When the inhalation device 400 detects at 935 that the pressure measurement exceeds a predetermined amount (which may indicate, for example, that a dose of medication has been administered to the user), the LED 132 may be in state 4 at 940. For example, the LED 132 may be illuminated in state 4. When the inhalation device 400 detects at 945 that the lever 424 returns to the closed position (e.g., the cover 491 is closed), the LED 132 may be in state 1 at 910. For example, the LED 132 may be off in state 1. In one or more embodiments, 925 and 930 may be omitted, with the inhalation device 400 proceeding from 920 to 935.
[0101] The LED 132 may be on, off, blinking, and / or illuminated in different colors to indicate different states. For example, the LED 132 may indicate state 2 in green and state 4 in blue. Further, an example state diagram may include states 1, 2, 3, and 4 of the LED 132, which may be any combination of the off state, the on state, and / or the blinking state. Furthermore, if the LED 132 is a light, the on state and / or the blinking state may be characterized by the light being illuminated in one or more of multiple colors. The indicators may use different blinking patterns. For example, an example state diagram is provided below in Table 2: [Table 2] TIFF0007620595000002.tif69155
[0102] In example 1, the LED is off in state A1 (e.g., when lever 424 is closed), flashes in state 2 (e.g., to indicate a dose is ready), flashes in state 3 (e.g., while the user is inhaling), and is on in state 4 (e.g., when a dose has been administered). In example 2, LED 132 is off in state 1, on in states 2 and 3, and off in state 4. In example 3, LED 132 is off in state 1, on in a first color in states 2 and 3, and on in a second color in state 4. In example 4, LED 132 is off in state A1, on in a first color in state 2, flashes in state 3, and on in a second color in state 4. In example 5, LED 132 is off in states 1, 2, and 3, and on in state 4. In example 6, the LED 132 is off in state 1, on in a first color in state 2, on in a second color in state 3, and on in a third color in state 4. There may be other ways of indicating states. For example, the indicator may include a multi-light and / or multi-color configuration. Additionally, the inhalation device 400 may include one or more visual indicators that progress through any combination of states, where each state is defined by one or more of the visual indicators being on, off, flashing, and / or illuminated in one or a combination of different colors.
[0103] Table 3 provides additional examples of states of the LED 132 of the inhalation device 400. Examples 7-9 may include any number or combination of states provided herein. [Table 3] TIFF0007620595000003.tif74161
[0104] The inhalation device 400 may determine that the flexible strip 401 is empty, for example, via a dose counter. The dose counter may be mechanical and / or electrical. For example, an electronic module of the inhalation device 400 may determine that the flexible strip 401 is empty. When the inhalation device 400 determines that the flexible strip 401 is empty, and when the lever 424 is subsequently actuated, the inhalation device 400 may keep the LED 132 in an off state. For example, this may indicate to the user that the inhalation device 400 is not ready for inhalation because there is no medication in the inhalation device 400. The inhalation device 400 may indicate that the flexible strip 401 is empty using one or more indication techniques described herein (e.g., a solid light, a colored light, a flashing light, one or more indicators, etc.).
[0105] Although not shown, the inhalation device 400 may include one or more additional indications, such as multiple LEDs. For example, the inhalation device 400 may further provide a dose reminder indication to the user. The dose reminder indication may indicate that it is time for the user to take a dose of medication. For example, the inhalation device 400 may provide a dose reminder to the user using one or more indicators (e.g., light, sound, tactile feedback, etc.).
[0106] Although primarily described in connection with visual indicators (e.g., one or more LEDs and / or light states), one or more of the embodiments / examples described herein may comprise other indicators. For example, the indicators may include visual indicators (e.g., one or more lights and / or light states), audible indicators (e.g., one or more buzzers / speakers and / or sounds), and / or haptic feedback indicators (e.g., one or more haptic feedback devices and / or haptic feedback states / actions).
Claims
1. 1. An inhaler comprising: a lever, the actuation of which is configured to prepare a dose of medicament for inhalation by a user; and an electronic module comprising a processor, a power supply, and a switch; the electronic module is configured to be in an off state before the lever is moved from a first position to a second position for the first time; the switch is configured to be actuated when the lever is moved from the first position to the second position; and the electronic module is configured to transition from the off state or the sleep state to an active state when the switch is actuated, the electronic module is configured to use more power when operating in the sleep state than when operating in the off state, and the electronic module is configured to use more power when operating in the active state than when operating in the sleep state; the electronic module is configured not to return to the off state after the lever is moved from the first position to the second position by the user for the first time, and the electronic module is configured to be in the sleep state when not in the off state or the active state; The electronic module further comprises: configured to start an internal counter in response to the transition from the off state and to time-stamp the actuation of the lever based on the internal counter. Inhaler.
2. a mouthpiece cover configured to be rotated about the body of the inhaler to expose the lever.
2. The inhaler of claim 1.
3. The lever is part of the mouthpiece cover.
3. The inhaler of claim 2.
4. and a mouthpiece cover configured to cover the lever when in a closed position and to expose the lever when in an open position.
2. The inhaler of claim 1.
5. the electronic module further comprises a sensor system; the electronic module is configured to, in response to the lever actuating the switch, power on the sensor system to detect inhalation by a user.
2. The inhaler of claim 1.
6. the electronic module further comprises a sensor system; the electronic module is configured to receive measurements from the sensor system and determine an inhalation parameter based on the received measurements.
2. The inhaler of claim 1.
7. The inhalation parameters include one or more of peak flow rate, time to peak flow rate, inhalation volume, or inhalation duration.
7. An inhaler according to claim 6.
8. The electronic module further comprises: starting an internal counter in response to the transition from the off state; determining a detected inhalation based on the measurements received from the sensor system; and configured to time stamp the detected inhalation based on the internal counter.
7. An inhaler according to claim 6.
9. the electronic module further comprises wireless communication circuitry; The electronic module comprises: generating a lever actuation event in response to actuation of the switch; and configured to transmit the lever actuation event to an external device using the wireless communication circuitry; 2. The inhaler of claim 1.
10. the electronic module further comprises a sensor system; the electronic module is configured to change from the active state to the sleep state when the electronic module determines that one or more measurements received from the sensor system are not within a predetermined range for a predetermined time.
2. The inhaler of claim 1.
11. the electronic module further comprises a sensor system; the electronic module is configured to store a timeout event and an associated timestamp when the lever is moved from the first position to the second position and a measurement received from the sensor system is not within a predetermined range within a predetermined time.
2. The inhaler of claim 1.
12. the electronic module is configured to change from the active state to the sleep state after the predetermined time.
12. An inhaler according to claim 11.
13. the electronic module further comprises a sensor system; The electronic module, when in the active state, receiving measurements from the sensor system; determining an inhalation parameter based on the measurements; storing said inhalation parameters in a memory of said electronic module; Notify the external device, and configured to transmit the inhalation parameters to the external device.
2. An inhaler according to claim 1.
Citation Information
Patent Citations
drug dispenser
JP2005533585A
Systems and assemblies for inflating and monitoring pressure within the retention cuff
JP2016515410A
Inhalation device with integrated electronic module
JP2020501855A
Metered-Dose Inhaler Counter and Metered-Dose Inhaler Including Such a Counter
US20140053833A1
Compliance-assisting module for an inhaler
WO2016030521A1